Literature DB >> 32104518

Response to: Comment on "Tapered Cuff versus Conventional Cuff for Ventilator-Associated Pneumonia in Ventilated Patients: A Meta-Analysis of Randomized Controlled Trials".

Xu An Huang1, Wei Min Huang2, Yan Ping Du3, Liu Xia Li4, Fang Fang Wu4, Shao Qing Hong4, Fang Xuan Tang4, Zhang Qiang Ye4.   

Abstract

Entities:  

Year:  2020        PMID: 32104518      PMCID: PMC7040401          DOI: 10.1155/2020/1601785

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


× No keyword cloud information.
We are very glad to hear from Maertens and Blot [1], and they are as concerned about the same important issues as we are. We also read their excellent paper published in critical care medicine [2]. In the study reported by Mahmoodpoor et al. in 2013 [3], which Maertens and Blot and us both selected, pneumonia was defined according to clinical radiology, laboratory findings, and clinically pulmonary infection score (CPIS), but not based on microbiological confirmation. We know that not all pneumonias in the clinic could be microbiologically confirmed because different doctors perform bronchoscopies in different ways. Sometimes, it is also possible that some doctors perform bronchoalveolar lavage or protective mini-bronchoalveolar lavage at bronchopulmonary segments where the pulmonary patch shadow is caused by heart failure or other noninfectious reasons. Thus, it does not mean that there is no pneumonia when no bacteria are successfully cultured in the lavage. Therefore, pneumonia as diagnosed by microbiological examination only represents a subset of all pneumonia cases. Diagnosis solely based on bacterial cultures of alveolar lavage or protective alveolar lavage often leads to misdiagnosis of pneumonia. In another study published by Monsel et al. in 2016 [4], in order to be consistent with the other studies we have chosen, we included the pneumonia diagnosed by clinically diagnostic criteria. Monsel's study [4] contains first postoperative pneumonia and second postoperative pneumonia. Maertens and Blot seem to have selected the first postoperative pneumonia episodes confirmed by microbiological examination. However, we only chose the second postoperative pneumonia herein, because we could not add the two postoperative pneumonias together, which would lead to duplication. In most of the studies included by us, the polyvinylchloride (PVC) cuffs were used, and many other studies suggested that polyurethane- (PU-) tapered cuffs showed no benefits on microaspiration reduction. Thus, only PVC cuffs in Philippart's study reported in 2014 [5] were included in our analysis. However, whether the cuff material might impact tracheal sealing remains to be further investigated. In Mahmoodpoor's study reported in 2017 [6], the tapped cuffs combined with subglottic secretion drainage (SSD) caused little bias in our study. As we know, Maertens's study also selected the cases in Mahmoodpoor's study published in 2013 [3] and another two studies reported by Saito, in which SSD was also used. These could also cause bias, and there are some other bias that could not be avoided, such as head of bed elevation, cuff pressure, and use of drugs for controlling gastric acid. All of these are known to affect the occurrence of ventilator-associated pneumonia. Our study only included the published studies but not the unpublished studies. Finally, we believe that we share with Maertens and Blot [1] the opinion that the tapered-cuff tracheal tube may not be superior to the standard-cuff tracheal tube in reducing ventilator-associated pneumonia (VAP) and intensive care unit (ICU) mortality.
  6 in total

1.  Randomized intubation with polyurethane or conical cuffs to prevent pneumonia in ventilated patients.

Authors:  François Philippart; Stéphane Gaudry; Laurent Quinquis; Nicolas Lau; Islem Ouanes; Samia Touati; Jean Claude Nguyen; Catherine Branger; Frédéric Faibis; Maha Mastouri; Xavier Forceville; Fekri Abroug; Jean Damien Ricard; Sophie Grabar; Benoît Misset
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

2.  Prevention of Ventilator-Associated and Early Postoperative Pneumonia Through Tapered Endotracheal Tube Cuffs: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Bert Maertens; Koen Blot; Stijn Blot
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

3.  Tapered-cuff Endotracheal Tube Does Not Prevent Early Postoperative Pneumonia Compared with Spherical-cuff Endotracheal Tube after Major Vascular Surgery: A Randomized Controlled Trial.

Authors:  Antoine Monsel; Qin Lu; Marine Le Corre; Hélène Brisson; Charlotte Arbelot; Corinne Vezinet; Marie-Hélène Fléron; Christina Ibanez-Estève; Farid Zerimech; Malika Balduyck; Felippe Dexheimer; Chunyao Wang; Olivier Langeron; Jean-Jacques Rouby; Liliane Bodin; Romain Deransy; Pierre Garçon; Hatem Douiri; Ismael Khalifa; Antoine Pons; Wen-Jie Gu; Fabien Koskas; Julien Gaudric
Journal:  Anesthesiology       Date:  2016-05       Impact factor: 7.892

4.  A prospective randomized trial of tapered-cuff endotracheal tubes with intermittent subglottic suctioning in preventing ventilator-associated pneumonia in critically ill patients.

Authors:  Ata Mahmoodpoor; Hadi Hamishehkar; Masoud Hamidi; Kamran Shadvar; Sarvin Sanaie; Samad Ej Golzari; Zahid Hussain Khan; Nader D Nader
Journal:  J Crit Care       Date:  2016-11-14       Impact factor: 3.425

5.  Comparison of prophylactic effects of polyurethane cylindrical or tapered cuff and polyvinyl chloride cuff endotracheal tubes on ventilator-associated pneumonia.

Authors:  Ata Mahmoodpoor; Ali Peyrovi-far; Hadi Hamishehkar; Zhaleh Bakhtyiari; Mir Mousa Mirinezhad; Masoud Hamidi; Samad Eslam Jamal Golzari
Journal:  Acta Med Iran       Date:  2013-08-07

6.  Comment on "Tapered Cuff versus Conventional Cuff for Ventilator-Associated Pneumonia in Ventilated Patients: A Meta-Analysis of Randomized Controlled Trials".

Authors:  Bert Maertens; Stijn Blot
Journal:  Can Respir J       Date:  2019-07-07       Impact factor: 2.409

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.